Hematopoietic stem cell transplantation for children with thalassemia major in China.

Abstract

Thalassemia is the most common single-gene disorder worldwide that is considered a major public health issue. Hematopoietic stem cell transplantation (HSCT) is the only curative treatment for thalassemia major, the form of the disease reflecting homozygosity for a mutant allele. In China, many patients with thalassemia major cannot financially afford life… (More)
DOI: 10.1002/pbc.22742

Topics

Cite this paper

@article{Fang2010HematopoieticSC, title={Hematopoietic stem cell transplantation for children with thalassemia major in China.}, author={Jian-pei Fang and Lu-Hong Xu}, journal={Pediatric blood & cancer}, year={2010}, volume={55 6}, pages={1062-5} }